Mackenzie Financial Corp Amarin Corp Plcuk Transaction History

Mackenzie Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$4.04 - $5.31 $293,457 - $385,707	-72,638 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.64 - $7.76 $24,573 - $52,387	6,751 Added 10.25%	72,638 $306,000
Q2 2020 Aug 13, 2020	SELL	$4.78 - $8.26 $15,874 - $27,431	-3,321 Reduced 4.8%	65,887 $455,000
Q1 2020 May 14, 2020	BUY	$4.0 - $21.53 $264 - $1,420	66 Added 0.1%	69,208 $276,000
Q4 2019 Feb 13, 2020	SELL	$13.94 - $24.12 $62,799 - $108,660	-4,505 Reduced 6.12%	69,142 $1.48 Million

Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $24,751 - $41,271	1,782 Added 2.48%	73,647 $1.12 Million
Q2 2019 Aug 14, 2019	SELL	$16.27 - $20.51 $216,716 - $273,193	-13,320 Reduced 15.64%	71,865 $1.39 Million
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $164,333 - $291,004	13,032 Added 18.06%	85,185 $1.77 Million
Q4 2018 Feb 06, 2019	BUY	$12.41 - $22.98 $895,418 - $1.66 Million	72,153 New	72,153 $982,000

184

87.9M

528K

219K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $278M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.